Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, October 14, 2020
[ Wed, Oct 14th 2020
] - WOPRAI
[ Wed, Oct 14th 2020
] - WOPRAI
[ Wed, Oct 14th 2020
] - WOPRAI
[ Wed, Oct 14th 2020
] - WOPRAI
[ Wed, Oct 14th 2020
] - WOPRAI
[ Wed, Oct 14th 2020
] - WOPRAI
[ Wed, Oct 14th 2020
] - WOPRAI
[ Wed, Oct 14th 2020
] - WOPRAI
[ Wed, Oct 14th 2020
] - WOPRAI
[ Wed, Oct 14th 2020
] - WOPRAI
[ Wed, Oct 14th 2020
] - WOPRAI
[ Wed, Oct 14th 2020
] - WOPRAI
[ Wed, Oct 14th 2020
] - WOPRAI
[ Wed, Oct 14th 2020
] - WOPRAI
[ Wed, Oct 14th 2020
] - WOPRAI
[ Wed, Oct 14th 2020
] - WOPRAI
[ Wed, Oct 14th 2020
] - WOPRAI
[ Wed, Oct 14th 2020
] - WOPRAI
[ Wed, Oct 14th 2020
] - WOPRAI
[ Wed, Oct 14th 2020
] - WOPRAI
[ Wed, Oct 14th 2020
] - WOPRAI
[ Wed, Oct 14th 2020
] - WOPRAI
[ Wed, Oct 14th 2020
] - WOPRAI
[ Wed, Oct 14th 2020
] - WOPRAI
[ Wed, Oct 14th 2020
] - WOPRAI
[ Wed, Oct 14th 2020
] - WOPRAI
[ Wed, Oct 14th 2020
] - WOPRAI
Tue, October 13, 2020
[ Tue, Oct 13th 2020
] - WOPRAI
Andrew Berens Maintained (BPMC) at Buy with Increased Target to $100 on, Oct 13th, 2020
Andrew Berens of Morgan Stanley, Maintained "Blueprint Medicines Corporation" (BPMC) at Buy with Increased Target from $92 to $100 on, Oct 13th, 2020.
Andrew has made no other calls on BPMC in the last 4 months.
There are 2 other peers that have a rating on BPMC. Out of the 2 peers that are also analyzing BPMC, 0 agree with Andrew's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Andrew
- Michael Schmitz of "Guggenheim" Maintained at Strong Buy with Increased Target to $106 on, Wednesday, September 23rd, 2020
- Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $110 on, Wednesday, July 15th, 2020
